Answers are grounded in this paper and cite their sources.
The pain VAS is a valid tool for measuring pain at one point in time. However, the pain VAS does not behave linearly and SRMs vary along the trait of pain. Consequently, Minimum Clinically Important Differences using raw data, or change scores in general, are invalid as these will either under- or overestimate true change; raw pain VAS data should not be used as a primary outcome measure or to inform parametric-based Randomised Controlled Trial power calculations in research studies; and Rasch analysis should be used to convert ordinal data to interval data prior to data interpretation.
No takes yet. Share an insight, caveat, or question.
Kersten et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: